ABSTRACT
Psoriasiform alopecia arising in patients on tumor necrosis factor-alpha inhibitors (anti-TNFs) is a newly described entity with a recognizable histopathological correlate. The manifestation of TNF-alpha inhibitor associated psoriasiform alopecia (TAIAPA) is perhaps not surprising given the well-recognized phenomenon of paradoxical psoriasiform eruptions, especially palmoplantar pustular psoriasis, as well as scalp psoriasis, seborrheic dermatitis, guttate psoriasis, and plaque-type psoriasiform eruptions, in patients treated with anti-TNFs (1-3).
